Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit

Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics

Roberto Clemente Health Clinic to Host Health Care Fair

Hundreds of residents who live in the remote communities of southwest Nicaragua will receive free healthcare at the Roberto Clemente Health Clinic’s Annual Health Care Fair from 9 a.m. to 2 p.m. on Saturday, February 4, in Limon 1 Tola, Rivas, Nicaragua. A team of more than 30 medical... - January 31, 2012 - The Roberto Clemente Health Clinic

U.S. Army’s Presidio of Monterey DFMWR Incorporates Proactive Solution to Bacteria

Long-lasting antimicrobial technology will fight bacteria growth 24/7 for up to 90 days with one application. ecoSolv Distribution, LLC and the United States Army’s Presidio of Monterey in California today announced the installation’s facilities will in part be treated with... - January 31, 2012 - ecoSolv Distribution LLC

Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics

Industry Presenters Will Focus on the Use and Benefits of Physiologic, Mechanistic Models in Drug Development - January 30, 2012 - Rosa & Co LLC

Colorado’s Bioscience Industry Leaders and Legislators Focus on 2012 Initiatives at Annual "BioScience Day at the Capitol"

Colorado BioScience Association (CBSA) is hosting its fourth annual "BioScience Day at the Capitol" on February 2. The CBSA is building upon one of its most successful years in its history, making impressive strides in the areas of industry advocacy, programming, marketing communications, membership and education. - January 30, 2012 - Colorado BioScience Association

BioResource International Supports the Inter-Faith Food Shuttle

BioResource International, Inc. (www.briworldwide.com) is proud to announce their continuing support of the Inter-Faith Food Shuttle (www.foodshutttle.org), through their sponsorship of the 18th Annual Taste of Hope Gala (http://tasteandblossoms.org/). The gala, benefiting the Inter-Faith Food... - January 29, 2012 - BioResource International, Inc

BioResource International, Inc. Presents Latest Research at the International Poultry Expo

Scientists from the Agricultural biotechnology company BioResource International, Inc. (www.briworldwide.com) presented their latest research at the International Poultry Science Forum held in conjunction with the International Poultry Expo in Atlanta from January 23-26, 2012... - January 29, 2012 - BioResource International, Inc

Novus Biologicals Added as New Preferred Vendor for the University of Washington

Novus Biologicals is excited to be a preferred vendor for the University of Washington. Novus’ extensive product line will soon be added to the UW online ordering system, and all UW researchers will now receive 5% off any order. Novus Biologicals is committed to developing and maintaining... - January 28, 2012 - Novus Biologicals

Sunsafe Rx®: the Pill That Protects Your Skin from the Sun

Napa Valley Bioscience announces the launch of Sunsafe Rx®: a natural, premium nutritional supplement that helps your skin naturally defend against sun damage. A revolutionary new product, Sunsafe Rx® is designed to defend against the aging effects of both UVA and UVB rays without affecting your body's natural production of Vitamin D. - January 27, 2012 - Napa Valley Bioscience

NovaTeinBio Now Offering Wider Range of ELISA Kit Testing Solutions

Cambridge, MA based biological reagents provider NovaTeinBio has recently announced that have added to the company’s exceptional selection of ELISA kit products. The company has made this move in order to continue to provide one of North America’s largest selections of ELISA kit... - January 27, 2012 - Novatein Biosciences

Clinical Trials GPS Shares 2011 Q4 Findings; Almost 40% of Trials Aimed at Seniors, Less Than 17% Funded by the Government

Internal data shows a trend towards female participants, a surprisingly low volume of smokers, majority are willing to stay overnight, and an average age of 42. - January 27, 2012 - Clinical Trials Institute

Pfizer and Rosa to Present at 2012 Keystone Symposia: Pathogenesis of Diabetes

Insulin degradation and the mechanisms controlling it have significant impact on glucose homeostasis and diabetes. - January 26, 2012 - Rosa & Co LLC

Clinical Financial Services (CFS) Expands Internationally with Office in Edinburgh, Scotland

Clinical Financial Services, LLC (CFS), a specialty service provider focused on the business and financial management activities for clinical trials, has expanded its global presence by opening a new office in Edinburgh, Scotland. April Mulroney, CA, CPA, having most recently served as Vice... - January 26, 2012 - Clinical Financial Services

G&G Vitamins Introduce New Line of Prenatal Products

One of the UK’s leading suppliers of vitamin products for women around the world, G&G Vitamins have recently announced they have expanded their line of prenatal vitamins to further help their clientele achieve the optimal nutritional intake during their pregnancy. - January 26, 2012 - G&G Vitamins

At-Home Allergy Kit for Identifying Culprit Foods Behind Ill-Health Available Through Better Control of Health

At-Home Food Intolerance Screening Kit Identifies the Over-Looked Culprit Behind the Ill-Health of Millions of Americans Available Through Better Control of Health - January 26, 2012 - Better Control of Health

Clinical Trials GPS Highlights New Diabetes Trials; Aims to Help the Over 25 Million Individuals in U.S. Affected by Diabetes

25.8 million children and adults in the United States - 8.3% of the population - have diabetes. This equates to $116 billion in direct medical costs, and another $58 billion in indirect costs. - January 25, 2012 - Clinical Trials Institute

Health IT Startup TrialX Wins NCI’s Developer Challenge for Cancer App

TrialX, an NYC based health IT company was declared a winner of a developer challenge organized by the National Cancer Institute for its application, Ask Dory. Ask Dory helps cancer patients find and connect with clinical trials near them effortlessly. - January 25, 2012 - Applied Informatics

Sun Born Natural Products Co. Reports Sponsorship Agreement with Texas United Football Association

Pamela Mitchell, first woman owner of an all men semi-pro football league in Texas, endorses Herbal Chi Balm, and signs sponsorship agreement with Sun Born. - January 25, 2012 - Sun Born Natural Products

Circle City Tickets Welcomes Super Bowl XLVI to Indianapolis

Circle City Tickets, the oldest ticket broker in Indiana, prepares for the first ever Super Bowl at Lucas Oil Stadium in Indianapolis, Indiana on February 5. - January 25, 2012 - Circle City Tickets

AnaSpec Expands SensoLyte® 520 Renin Assay Kits Collection

AnaSpec, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit now provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using their proprietary 5-FAM/QXL™ 520 fluorescence resonance... - January 25, 2012 - AnaSpec, EGT Group

AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay

AnaSpec, EGT Group is pleased to announce the release of an ultrasensitive ELISA assay for quantitatingα-synuclein. The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and... - January 25, 2012 - AnaSpec, EGT Group

AnaSpec Offers Speedy 28-Day Custom Polyclonal Antibody Service

When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - January 25, 2012 - AnaSpec, EGT Group

Red Cedar Technology Welcomes Robert R. Ryan as President and CEO

Former Board Chairman transitions into new role on company’s leadership team. - January 25, 2012 - Red Cedar Technology

Zenagen Unveils New Hair Thickening Revitalization System Plans

Popular Zenagen Hair Care Brand Prepares for Release of New Natural Fusion Focused Products Directed at Visibly Thicker, Stronger, and More Voluminous Hair. - January 25, 2012 - Nutraceutical Research Innovations, LLC

Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012

Integration of PK/PD and mechanistic physiological models improves drug development in infants. - January 24, 2012 - Rosa & Co LLC

BioPharm Systems to Host Webinar on the Ins and Outs of CTMS Data Migration

Leading provider of Oracle's clinical trial, data, and drug safety software will discuss how the data in an existing clinical trial management system should be handled when migrating to a new application. - January 22, 2012 - BioPharm Systems

New, Interactive Social Media Fundraising Campaign, Arrest ALS, Launched

Innovative fundraising concept leverages social media to raise money and awareness to end ALS. - January 22, 2012 - ALS Therapy Development Institute

BioRegenerative Sciences, Inc. Signs Memorandum of Understanding with Nurture Earth Pvt. Ltd. to Form Stem Cell Joint Venture in India

BioRegenerative Sciences, Inc. Signs Memorandum of Understanding with Nurture Earth Pvt. Ltd. to Form Stem Cell Joint Venture in India

BioRegenerative Sciences, Inc. of San Diego, CA signs MOU with Nurture Earth, Pvt., Ltd. of India to form joint venture called BioRegenerative Sciences India (BRS India). The new joint venture, BRS India will produce, test, register, and market and sell BRS' stem cell-based therapeutic products in the Asian markets. - January 20, 2012 - BioRegenerative Sciences, Inc.

DNP Announces 53.6% Sales Growth in 2011

DNP International experiences substantial growth in 2011. - January 20, 2012 - DNP International Co., Inc.

DNP International Announces the Launch of Their New Website

DNP International launched a new and improved website to create a one stop solution to their products, services and solutions. - January 20, 2012 - DNP International Co., Inc.

Premiere pAGG Supplement Supplier Signs Exclusive Deal with GNC

Naturally Occurring, Stimulant-Free Weight Loss Pill Pioneered in New York Times Best-Seller, The 4-Hour Body, Now to be Sold in GNC's top performing 1900 Stores Nationwide - January 19, 2012 - NewHealth Solutions

Arthritis and Bacterial Infection Research Nabs Win for Stevens Student

Stevens undergrad demonstrates how bacteria infection plays a role in arthritis. - January 19, 2012 - Stevens Institute of Technology

Pratt & Miller Engineering Enters Sales Agent Agreement with Red Cedar Technology

Industry-leading engineering firm will resell HEEDS MDO software. - January 19, 2012 - Red Cedar Technology

AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit

AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NAD/NADH. - January 19, 2012 - AnaSpec, EGT Group

AnaSpec Includes Ghrelin and Obestatin Peptides in GO® Collection

AnaSpec, EGT Group, a leading provider of integrated proteomic and genomic solutions, offers a wide range of ghrelin and obestatin GO® (catalog) peptides for research use. In 1999, Kojima and his group (1) reported the discovery of a growth hormone secretagogue that is involved in the release... - January 19, 2012 - AnaSpec, EGT Group

NovaTeinBio Advancing Research with New CD Antigen Solutions

Boston based biological reagents provider NovaTeinBio has recently announced to their client base that they will now be providing more CD (clusters of differentiation) antigen products than ever before. These new additions come as research companies across America look to specialists such as... - January 19, 2012 - Novatein Biosciences

Life Vessel of the Prairie Announces Grand Opening in Wichita, Kansas

Life Vessel of the Prairie, houses the Life Vessel®, a patented, 510K FDA cleared non-invasive technology and technique by which frequency, vibration, sound and light waves are non-invasively applied to the human body in a resonance chamber, resulting in the body being able to perform its innate natural ability to heal itself. - January 17, 2012 - Hansa Center for Optimum Health

AnaSpec Highlights Its Proprietary HiLyte Fluor™ Dye Collection

AnaSpec, EGT Group’s proprietary HiLyte Fluor™ dyes are a series of excellent fluorescent labeling dyes with fluorescence emissions that span the full visible and near infrared spectrum. The hydrophilic property of most of the HiLyte Fluor™ dyes makes conjugations to protein... - January 17, 2012 - AnaSpec, EGT Group

Nanion Celebrates Its 10th Anniversary - Still with a Strong Focus on New Innovations

Today, Nanion celebrates 10 years of innovation, scientific product development and successful roll-outs of several product families. Nanion is a success story of organic, revenue-based company growth and dedicated young professionals. - January 17, 2012 - Nanion Technologies GmbH

Waxelene Adds Pediatrician Testimonials to Growing List of Satisfied Customers

Company’s eco-friendly petroleum jelly alternative available in a growing number of retail outlets across the country. - January 16, 2012 - Waxelene

CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy

CrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within... - January 16, 2012 - CrystalGenomics, Inc.

Online Retailer Announces Round Trip Toiletry Delivery Service

Online Retailer Announces Round Trip Toiletry Delivery Service

Ogomo.com announces their round-trip toiletry supply service. This service will allow travelers to send their toiletries to their hotel and return them back home after their trip. - January 13, 2012 - Ogomo, LLC

John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. - January 12, 2012 - Cambridge Healthtech Institute

AGEOFF® Clinically Proven Cosmetic Nutrition Now Available at Alive Health Centres and Sister Chains Across Canada

NuvoCare Health Science Inc. of Toronto, Ontario (Canada) is pleased to announce the retail partnership with Alive Health Centres and sister chains for its blockbuster brands AGEOFF® Face & Body Nutrition™, AGEOFF Wrinkle-Reduction Serum™, and WeightOFF® Target, Release... - January 12, 2012 - NuvoCare Health Sciences Inc.

SignaBlok Awarded DARPA Contract to Support New Technology to Combat Sepsis

SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to introduce company’s new approach to the prevention and treatment of sepsis (blood poisoning). - January 12, 2012 - SignaBlok, Inc.

Aciont® To Present on VisulexTM Technologies at the 4th Ocular & Drug Discovery Conference

Aciont Inc. announced today that both Kongnara Papangkorn, Research Director and Sarah Abdulla Molokhia, Scientific Research Consultant, will present on Aciont’s Visulex technologies at the Global Technology Community’s 4th Ocular & Drug Discovery Conference, February 27-28, 2012,... - January 12, 2012 - Aciont Inc.

Senomyx to Webcast Corporate Presentation at the 14th Annual Needham Growth Conference

Senomyx, Inc. (NASDAQ: SNMX), a leading company focused on using proprietary taste receptor technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Kent Snyder, the Company's Chief Executive Officer, and John... - January 12, 2012 - Senomyx, Inc.

Autoscribe Launches US Operation

The formation of Autoscribe Informatics Inc., a wholly owned subsidiary of Autoscribe Ltd, has been announced. Based in Falmouth, MA, USA, it gives Autoscribe, the developers of Matrix software products, a much stronger presence in the US and Canadian markets. Zumatrix Inc. operated as... - January 12, 2012 - Autoscribe Informatics

IAOP Launches Financial Services Chapter

Inaugural Webinar to be Held in Conjunction with UK and Ireland Chapter Meeting - January 12, 2012 - IAOP

CrystalGenomics to Present at J.P. Morgan Healthcare Conference on January 12

CrystalGenomics, Inc. (KOSDAQ: CRYSTAL (083790)), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that Joong Myung Cho, Ph.D., President & CEO, will present an overview of CrystalGenomics’ business strategy and an update on its development pipeline on... - January 11, 2012 - CrystalGenomics, Inc.

Press Releases 5,751 - 5,800 of 8,733